Skip to content

Nasdaq · CIK 0001636282

SYRE Spyre Therapeutics, Inc.

Insider trading from SEC Form 4. Last filing 10 d ago. Close $85.69 on Oct 9, 2026, +353% from the 52-week low and -21% from the high.

Last 90 days

Net insider value
-$12M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
6
$12M by 3 insiders
Insiders on file
9
with a Form 4 at this company

Price and insider trades, last year

SYREOct 9, 2026 · close 85.69

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Spyre Therapeutics, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
37WeakScott L Burrows
Chief Financial Officer
sell
$2.3M
25,000 shares
-26%+460% from low-18% from high
40ModerateHeidy King-Jones
See Remarks
sell
$2.6M
28,933 shares
-91%+466% from low-17% from high
45ModerateCameron Turtle
Chief Executive Officer
sell
$1.4M
15,000 shares
-3%+466% from low-17% from high
32WeakScott L Burrows
Chief Financial Officer
sell
$2.3M
25,732 shares
-24%+497% from low-19% from high
40ModerateHeidy King-Jones
See Remarks
sell
$2.5M
28,399 shares
-92%+497% from low-19% from high
45ModerateCameron Turtle
Chief Executive Officer
sell
$1.3M
15,000 shares
-3%+497% from low-19% from high
41ModerateScott L Burrows
Chief Financial Officer
sell
$300k
18,428 shares
-16%+41% from low-58% from high
13WeakJeffrey W. Albers
director
sell
$246k
6,700 shares
-20%-
0WeakJeffrey W. Albers
director
sell
$11k
300 shares
-1%-

Transactions

The last 56 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 30, 2026Scott L Burrows
Chief Financial Officer
MOption exercise
Common Stock10b5-1
+17,500$14.50$254k97,26210 d ago
Oct 1, 2026Cameron Turtle
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-600$89.14$53k551,94010 d ago
Oct 1, 2026Heidy King-Jones
See Remarks
MOption exercise
Common Stock10b5-1
+28,933$14.50$420k31,77810 d ago
Sep 30, 2026Scott L Burrows
Chief Financial Officer
SOpen-market sale
Common Stock10b5-1
-17,500$89.89$1.6M79,76210 d ago
Oct 1, 2026Cameron Turtle
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-2,683$90.10$242k549,25710 d ago
Oct 1, 2026Heidy King-Jones
See Remarks
SOpen-market sale
Common Stock10b5-1
-400$89.24$36k31,37810 d ago
Oct 1, 2026Scott L Burrows
Chief Financial Officer
MOption exercise
Common Stock10b5-1
+7,500$14.50$109k87,26210 d ago
Oct 1, 2026Cameron Turtle
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-2,638$91.49$241k546,61910 d ago
Oct 1, 2026Heidy King-Jones
See Remarks
SOpen-market sale
Common Stock10b5-1
-16,605$90.35$1.5M14,77310 d ago
Oct 1, 2026Heidy King-Jones
See Remarks
SOpen-market sale
Common Stock10b5-1
-7,228$91.35$660k7,54510 d ago
Oct 1, 2026Scott L Burrows
Chief Financial Officer
SOpen-market sale
Common Stock10b5-1
-600$89.07$53k86,66210 d ago
Oct 1, 2026Cameron Turtle
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-3,989$92.31$368k542,63010 d ago
Oct 1, 2026Heidy King-Jones
See Remarks
SOpen-market sale
Common Stock10b5-1
-2,100$92.70$195k5,44510 d ago
Oct 1, 2026Scott L Burrows
Chief Financial Officer
SOpen-market sale
Common Stock10b5-1
-1,500$90.27$135k85,16210 d ago
Oct 1, 2026Cameron Turtle
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-4,990$93.37$466k537,64010 d ago
Oct 1, 2026Cameron Turtle
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-100$93.91$9,391537,54010 d ago
Oct 1, 2026Scott L Burrows
Chief Financial Officer
SOpen-market sale
Common Stock10b5-1
-2,100$91.92$193k83,06210 d ago
Oct 1, 2026Heidy King-Jones
See Remarks
SOpen-market sale
Common Stock10b5-1
-2,600$93.46$243k2,84510 d ago
Oct 1, 2026Scott L Burrows
Chief Financial Officer
SOpen-market sale
Common Stock10b5-1
-3,071$92.95$285k79,99110 d ago
Oct 1, 2026Heidy King-Jones
See Remarks
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-28,933$0.00$0482,47810 d ago
Oct 1, 2026Scott L Burrows
Chief Financial Officer
SOpen-market sale
Common Stock10b5-1
-229$93.57$21k79,76210 d ago
Sep 30, 2026Scott L Burrows
Chief Financial Officer
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-17,500$0.00$0319,85710 d ago
Oct 1, 2026Scott L Burrows
Chief Financial Officer
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-7,500$0.00$0312,35710 d ago
Sep 1, 2026Cameron Turtle
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-2,500$86.36$216k565,04039 d ago
Sep 1, 2026Heidy King-Jones
See Remarks
MOption exercise
Common Stock10b5-1
+27,999$14.50$406k30,84439 d ago
Sep 1, 2026Scott L Burrows
Chief Financial Officer
MOption exercise
Common Stock10b5-1
+7,500$14.50$109k105,49439 d ago
Sep 1, 2026Cameron Turtle
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-8,400$87.15$732k556,64039 d ago
Sep 1, 2026Heidy King-Jones
See Remarks
SOpen-market sale
Common Stock10b5-1
-4,845$86.40$419k25,99939 d ago
Sep 1, 2026Scott L Burrows
Chief Financial Officer
SOpen-market sale
Common Stock10b5-1
-900$86.25$78k104,59439 d ago
Sep 1, 2026Scott L Burrows
Chief Financial Officer
SOpen-market sale
Common Stock10b5-1
-4,384$87.11$382k100,21039 d ago
Sep 1, 2026Cameron Turtle
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-3,700$88.06$326k552,94039 d ago
Sep 1, 2026Heidy King-Jones
See Remarks
SOpen-market sale
Common Stock10b5-1
-16,548$87.20$1.4M9,45139 d ago
Sep 1, 2026Scott L Burrows
Chief Financial Officer
SOpen-market sale
Common Stock10b5-1
-2,016$88.03$177k98,19439 d ago
Sep 1, 2026Cameron Turtle
Chief Executive Officer
SOpen-market sale
Common Stock10b5-1
-400$89.07$36k552,54039 d ago
Sep 1, 2026Heidy King-Jones
See Remarks
SOpen-market sale
Common Stock10b5-1
-6,206$88.17$547k3,24539 d ago
Sep 1, 2026Heidy King-Jones
See Remarks
SOpen-market sale
Common Stock10b5-1
-400$89.38$36k2,84539 d ago
Sep 1, 2026Scott L Burrows
Chief Financial Officer
SOpen-market sale
Common Stock10b5-1
-200$89.04$18k97,99439 d ago
Sep 2, 2026Heidy King-Jones
See Remarks
MOption exercise
Common Stock10b5-1
+400$14.50$5,8003,24539 d ago
Sep 2, 2026Scott L Burrows
Chief Financial Officer
SOpen-market sale
Common Stock10b5-1
-18,232$89.35$1.6M79,76239 d ago
Sep 1, 2026Scott L Burrows
Chief Financial Officer
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-7,500$0.00$0337,35739 d ago
Sep 2, 2026Heidy King-Jones
See Remarks
SOpen-market sale
Common Stock10b5-1
-400$90.00$36k2,84539 d ago
Sep 1, 2026Heidy King-Jones
See Remarks
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-27,999$0.00$0511,81139 d ago
Sep 2, 2026Heidy King-Jones
See Remarks
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-400$0.00$0511,41139 d ago
Sep 2, 2025Scott L Burrows
Chief Financial Officer
SOpen-market sale
Common Stock
-18,428$16.26$300k97,994Sep 3, 2025
May 29, 2025Fairmount Funds Management LLC
director
AGrant or award
Stock Option (Right to Buy)derivativeindirect: By Peter Harwin
+25,000$0.00$025,000Jun 2, 2025
May 29, 2025Laurie Stelzer
director
AGrant or award
Stock Option (Right to Buy)derivative
+25,000$0.00$025,000Jun 2, 2025
May 29, 2025Sandra Milligan
director
AGrant or award
Stock Option (Right to Buy)derivative
+25,000$0.00$025,000Jun 2, 2025
May 29, 2025Mark C. McKenna
director
AGrant or award
Stock Option (Right to Buy)derivative
+25,000$0.00$025,000Jun 2, 2025
May 29, 2025Michael Thomas Henderson
director
AGrant or award
Stock Option (Right to Buy)derivative
+25,000$0.00$025,000Jun 2, 2025
May 29, 2025Jeffrey W. Albers
director
AGrant or award
Stock Option (Right to Buy)derivative
+25,000$0.00$025,000Jun 2, 2025
May 29, 2025Fairmount Funds Management LLC
director
AGrant or award
Stock Option (Right to Buy)derivativeindirect: By Tomas Kiselak
+25,000$0.00$025,000Jun 2, 2025
Jan 15, 2025Scott L Burrows
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+95,500$0.00$095,500Jan 17, 2025
Jan 15, 2025Heidy King-Jones
See Remarks
AGrant or award
Stock Option (Right to Buy)derivative
+95,500$0.00$095,500Jan 17, 2025
Jan 10, 2025Michael Thomas Henderson
director
JOther
Common Stock
+105,379$0.00$0105,379Jan 14, 2025
Nov 6, 2024Jeffrey W. Albers
director
SOpen-market sale
Common Stockindirect: By Sessions LLC10b5-1
-6,700$36.76$246k27,360Nov 8, 2024
Oct 25, 2024Jeffrey W. Albers
director
SOpen-market sale
Common Stockindirect: By Sessions LLC10b5-1
-300$36.43$11k34,060Oct 28, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.